![](https://adventls.com/wp-content/uploads/2022/12/Advent_Portfolio_Cardiokine_L.jpg)
Clinical development of cardio-renal drugs
Cardiokine was a specialty pharmaceutical company founded around the licensing of Lixivaptan from Wyeth Pharmaceuticals in 2004. Lixivaptan is a sodium sparing diuretic that had completed multiple Phase I and Phase II trials.
CEO Amber Salzman
Advent Contact Shahzad Malik